1. Home
  2. SNY vs LRCX Comparison

SNY vs LRCX Comparison

Compare SNY & LRCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • LRCX
  • Stock Information
  • Founded
  • SNY 1994
  • LRCX 1980
  • Country
  • SNY France
  • LRCX United States
  • Employees
  • SNY N/A
  • LRCX N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • LRCX Industrial Machinery/Components
  • Sector
  • SNY Health Care
  • LRCX Technology
  • Exchange
  • SNY Nasdaq
  • LRCX Nasdaq
  • Market Cap
  • SNY 113.4B
  • LRCX 126.4B
  • IPO Year
  • SNY N/A
  • LRCX N/A
  • Fundamental
  • Price
  • SNY $46.97
  • LRCX $121.90
  • Analyst Decision
  • SNY Buy
  • LRCX Buy
  • Analyst Count
  • SNY 4
  • LRCX 26
  • Target Price
  • SNY $61.50
  • LRCX $106.68
  • AVG Volume (30 Days)
  • SNY 2.7M
  • LRCX 10.4M
  • Earning Date
  • SNY 10-24-2025
  • LRCX 10-22-2025
  • Dividend Yield
  • SNY 3.40%
  • LRCX 0.75%
  • EPS Growth
  • SNY 118.56
  • LRCX 43.10
  • EPS
  • SNY 8.65
  • LRCX 4.15
  • Revenue
  • SNY $53,714,621,258.00
  • LRCX $18,435,591,000.00
  • Revenue This Year
  • SNY $1.53
  • LRCX $10.18
  • Revenue Next Year
  • SNY $7.06
  • LRCX $9.80
  • P/E Ratio
  • SNY $5.43
  • LRCX $29.47
  • Revenue Growth
  • SNY 15.65
  • LRCX 23.68
  • 52 Week Low
  • SNY $44.73
  • LRCX $56.32
  • 52 Week High
  • SNY $60.12
  • LRCX $123.28
  • Technical
  • Relative Strength Index (RSI)
  • SNY 43.02
  • LRCX 78.10
  • Support Level
  • SNY $46.50
  • LRCX $104.46
  • Resistance Level
  • SNY $47.69
  • LRCX $106.37
  • Average True Range (ATR)
  • SNY 0.68
  • LRCX 2.91
  • MACD
  • SNY -0.18
  • LRCX 2.06
  • Stochastic Oscillator
  • SNY 36.14
  • LRCX 95.27

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About LRCX Lam Research Corporation

Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.

Share on Social Networks: